Neutra Corp. (NTRR) Building Vertical CBD Profile on Soft Gel, Sports Cream Foundation

• Neutra Corp. is a wellness product development and acquisition company focused on the potential of cannabidiol as a natural therapeutic
• Neutra’s recently acquired Vivis subsidiary has developed a quick absorption soft gel and an athletic use topical cream for CBD consumers
• The sports cream’s development occurs at a time when athletic agencies, such as the World Anti-Doping Agency (WADA) and U.S.A. Triathlon, are taking a more favorable turn toward CBD as a muscle pain therapeutic
• CBD products are expected to drive a multi-billion-dollar market in the United States by 2024, and athletic endorsement could play a significant role in its fortunes

Neutra Corp. (OTCQB: NTRR), a company dedicated to promoting wellness solutions through ongoing research and development, is focusing its energies on several potential acquisitions that are designed to make Neutra a more vertically integrated company capable of competing in the skyrocketing CBD (cannabidiol) market, according to a recent Form 8-K filing (http://ibn.fm/hYmXO).

“Our overall goal is to become a vertically integrated company from cultivation to manufacturing to formulation of products, and then to distribution and retail sales,” CEO Sydney Jim said during a NetworkNewsAudio interview on the company’s direction (http://ibn.fm/CeRW8).

The company markets a pair of CBD products currently under its just-acquired subsidiary VIVIS Corp. — its Hemp Extract Crystalline Soft Gels are designed to provide the most efficient CBD ingestion method available, using a medium-chain triglyceride (MCT) binding agent for rapid absorption in lieu of liquid dilution, and its Hemp Extract Sports Menthol Cream offers transdermal CBD delivery through the skin to battle aches and pains that result from inflammation (http://ibn.fm/dx8iC).

Vivis’ products boast a 99 percent or higher grade of hemp-extracted crystalline CBD.

The early-stage development company plans to utilize a nutraceutical contractor to private label all of Neutra’s products, manufacturing them as the company’s unique brand (http://ibn.fm/wykum). In the meantime, Neutra will also pursue the usual investment avenues for funding its vision of developing natural remedies that promote the body’s ability to heal and maintain itself.

Cannabis researchers BDS Analytics and Arcview Market Research have issued a market forecast that anticipates the collective market for CBD sales in the United States alone will surpass $20 billion by 2024 (http://ibn.fm/I9cGm). The Brightfield Group issued a similar forecast but maintains a more cautionary stance, noting the lack of FDA approval for dietary supplements and food products could reduce the market size to only $4.4 billion by 2022. But granted that the market size was $0.6 billion last year, even the minimum increase is significant (http://ibn.fm/RqzbU).

Acceptance by the enormous professional sports machine could drive a sea change in revenues. A number of pro athletes and former athletes already own interests in CBD product companies, and have spoken out about the potential benefits of using it to manage muscles and joint complaints. Although the non-intoxicating compound is currently still banned by the National Football League (NFL) and the National Basketball Association (NBA), athletes have reserved expectations that the policies may eventually change (http://ibn.fm/e4xqL).

U.S.A. Triathlon made news this month as the first national governing body of an American sport to make a sponsorship deal with a company that sells products containing CBD. Some privately controlled sports organizations have also forged relationships with CBD companies, but U.S.A. Triathlon is a national governing body of an Olympic sport that must abide by the World Anti-Doping Agency’s (WADA’s) regulations for international competition. However WADA removed CBD from its list of banned substances last year, opening the door for elite athletes to use and endorse CBD products (http://ibn.fm/v3Do5).

Rocky Harris, chief executive of U.S.A. Triathlon, commented on the sponsorship deal that “Athletes prefer not to take prescription drugs. They want organic and healthy. They want to find something more natural.”

“We’re definitely hitting the market at the best possible time,” Jim stated in a news release about Neutra’s sports cream production (http://ibn.fm/g8cNz). “With one in five Americans participating in a sport or exercising regularly, there’s going to be a lot of interest in our product, especially when our cream will be consistency and potency assured by third-party testing. That’s a key market differentiator consumers will appreciate.”

For more information, visit the company’s website at www.NeutraInc.com

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at  http://ibn.fm/NTRR

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php